Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
FDA Still Soliciting Applications For START Pilot As Deadline For Rare Disease Program Looms
Feb 28 2024
•
By
Brenda Sandburg
and
Nielsen Hobbs
FDA pilot program aims to get rare disease treatments across the finish line faster • Source: Shutterstock
More from Rare Diseases
More from Pink Sheet